# IV Iron Treatment of Restless Legs Syndrome

> **NCT02484768** · PHASE2 · WITHDRAWN · sponsor: **Pharmacosmos A/S**

## Conditions studied

- Restless Legs Syndrome

## Interventions

- **DRUG:** Iron isomaltoside 1000
- **DRUG:** Sodium Chloride 0.9%

## Key facts

- **NCT ID:** NCT02484768
- **Lead sponsor:** Pharmacosmos A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-01
- **Primary completion:** 2015-02
- **Final completion:** 2015-02
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** as per GCP sponsor/company decision
- **Last updated:** 2015-06-30

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02484768

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02484768, "IV Iron Treatment of Restless Legs Syndrome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02484768. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*